• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

迈向 HIV 治愈之路:超越柏林和伦敦。

On the Road to a HIV Cure: Moving Beyond Berlin and London.

机构信息

Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114, USA; Harvard Medical School, 25 Shattuck Street, Boston, MA 02115, USA.

Harvard Medical School, 25 Shattuck Street, Boston, MA 02115, USA; Brigham and Women's Hospital, 75 Francis Street, Boston, MA 02115, USA.

出版信息

Infect Dis Clin North Am. 2019 Sep;33(3):857-868. doi: 10.1016/j.idc.2019.04.007.

DOI:10.1016/j.idc.2019.04.007
PMID:31395147
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6814144/
Abstract

The Berlin patient, a famous example for human immunodeficiency virus (HIV) cure, had received a bone marrow transplantation with an HIV resistance mutation. The authors describe his case and others that had shown HIV control, like the Mississippi baby who was started on antiretroviral therapy very early after birth, and posttreatment controllers, like the VISCONTI cohort. Moreover, the authors outline various strategies, oftentimes informed by these individuals, that have been tried in vitro, in animal models, or in human trials, to deplete the latent reservoir, which is considered the basis of HIV persistence and the obstacle to cure.

摘要

柏林病人是人类免疫缺陷病毒 (HIV) 治愈的著名范例,他接受了带有 HIV 耐药突变的骨髓移植。作者描述了他的病例和其他一些 HIV 得到控制的病例,如密西西比婴儿,他在出生后非常早期就开始接受抗逆转录病毒治疗,以及治疗后控制者,如 VISCONTI 队列。此外,作者概述了各种策略,这些策略通常是基于这些个体的信息,已经在体外、动物模型或人体试验中尝试过,以耗尽潜伏库,这被认为是 HIV 持续存在和治愈障碍的基础。

相似文献

1
On the Road to a HIV Cure: Moving Beyond Berlin and London.迈向 HIV 治愈之路:超越柏林和伦敦。
Infect Dis Clin North Am. 2019 Sep;33(3):857-868. doi: 10.1016/j.idc.2019.04.007.
2
Knowledge From London and Berlin: Finding Threads to a Functional HIV Cure.伦敦与柏林的经验:探寻功能性 HIV 治愈方法。
Front Immunol. 2021 May 27;12:688747. doi: 10.3389/fimmu.2021.688747. eCollection 2021.
3
The potential of engineered antibodies for HIV-1 therapy and cure.工程抗体在 HIV-1 治疗和治愈中的潜力。
Curr Opin Virol. 2019 Oct;38:70-80. doi: 10.1016/j.coviro.2019.07.007. Epub 2019 Aug 15.
4
Which therapeutic strategy will achieve a cure for HIV-1?哪种治疗策略能治愈 HIV-1?
Curr Opin Virol. 2016 Jun;18:14-9. doi: 10.1016/j.coviro.2016.02.001. Epub 2016 Mar 15.
5
Virus-driven Inflammation Is Associated With the Development of bNAbs in Spontaneous Controllers of HIV.病毒驱动的炎症与HIV自发控制者体内广谱中和抗体的产生有关。
Clin Infect Dis. 2017 Apr 15;64(8):1098-1104. doi: 10.1093/cid/cix057.
6
Towards HIV-1 remission: potential roles for broadly neutralizing antibodies.迈向HIV-1缓解:广泛中和抗体的潜在作用。
J Clin Invest. 2016 Feb;126(2):415-23. doi: 10.1172/JCI80561. Epub 2016 Jan 11.
7
HIV-1 functional cure: will the dream come true?HIV-1功能性治愈:梦想会成真吗?
BMC Med. 2015 Nov 20;13:284. doi: 10.1186/s12916-015-0517-y.
8
A multi-step pace towards a cure for HIV: kick, kill, and contain.向治愈艾滋病迈进的多步骤计划:踢、杀、控。
AIDS Rev. 2013 Jul-Sep;15(3):190-1.
9
Chimeric Antigen Receptor T Cells Guided by the Single-Chain Fv of a Broadly Neutralizing Antibody Specifically and Effectively Eradicate Virus Reactivated from Latency in CD4+ T Lymphocytes Isolated from HIV-1-Infected Individuals Receiving Suppressive Combined Antiretroviral Therapy.由广泛中和抗体的单链Fv引导的嵌合抗原受体T细胞可特异性有效地根除从接受抑制性联合抗逆转录病毒疗法的HIV-1感染个体分离出的CD4 + T淋巴细胞中潜伏激活的病毒。
J Virol. 2016 Oct 14;90(21):9712-9724. doi: 10.1128/JVI.00852-16. Print 2016 Nov 1.
10
Persistence of wild-type virus and lack of temporal structure in the latent reservoir for human immunodeficiency virus type 1 in pediatric patients with extensive antiretroviral exposure.长期接受抗逆转录病毒治疗的儿科患者中,1型人类免疫缺陷病毒潜伏库中野生型病毒的持续存在及缺乏时间结构。
J Virol. 2002 Sep;76(18):9481-92. doi: 10.1128/jvi.76.18.9481-9492.2002.

引用本文的文献

1
Low prevalence of HIV in the northern Cameroon: contribution of some AIDS restriction genes and potential implications for gene therapy.喀麦隆北部地区人类免疫缺陷病毒(HIV)低流行率:某些艾滋病限制基因的作用及其对基因治疗的潜在影响
Front Genet. 2024 Sep 13;15:1447971. doi: 10.3389/fgene.2024.1447971. eCollection 2024.
2
Kaempferol: A Review of Current Evidence of Its Antiviral Potential.山奈酚:其抗病毒潜力的当前证据综述。
Int J Mol Sci. 2023 Nov 14;24(22):16299. doi: 10.3390/ijms242216299.
3
Peptide Triazole Inhibitors of HIV-1: Hijackers of Env Metastability.HIV-1的肽三唑抑制剂:Env亚稳定性的劫持者
Curr Protein Pept Sci. 2023;24(1):59-77. doi: 10.2174/1389203723666220610120927.
4
Role of Early Life Cytotoxic T Lymphocyte and Natural Killer Cell Immunity in Paediatric HIV Cure/Remission in the Anti-Retroviral Therapy Era.抗逆转录病毒治疗时代儿童 HIV 治愈/缓解中早期细胞毒性 T 淋巴细胞和自然杀伤细胞免疫的作用。
Front Immunol. 2022 May 11;13:886562. doi: 10.3389/fimmu.2022.886562. eCollection 2022.
5
Irreversible Loss of HIV-1 Proviral Competence in Myeloid Cells upon Suppression of NF-κB Activity.NF-κB 活性抑制导致髓样细胞中 HIV-1 前病毒的竞争能力不可逆转丧失。
J Virol. 2022 Jun 22;96(12):e0048422. doi: 10.1128/jvi.00484-22. Epub 2022 May 23.
6
Detection of CCR5Δ32 Mutant Alleles in Heterogeneous Cell Mixtures Using Droplet Digital PCR.使用液滴数字PCR检测异质细胞混合物中的CCR5Δ32突变等位基因
Front Mol Biosci. 2022 Feb 21;9:805931. doi: 10.3389/fmolb.2022.805931. eCollection 2022.
7
Identifying CCR5 coreceptor populations permissive for HIV-1 entry and productive infection: implications for in vivo studies.鉴定允许 HIV-1 进入和产生感染的 CCR5 核心受体群体:对体内研究的意义。
J Transl Med. 2022 Jan 24;20(1):39. doi: 10.1186/s12967-022-03243-8.
8
Why the HIV Reservoir Never Runs Dry: Clonal Expansion and the Characteristics of HIV-Infected Cells Challenge Strategies to Cure and Control HIV Infection.为何 HIV 储存库不会枯竭:克隆扩增和受 HIV 感染细胞的特征对治愈和控制 HIV 感染的策略提出挑战。
Viruses. 2021 Dec 14;13(12):2512. doi: 10.3390/v13122512.
9
Microglia: The Real Foe in HIV-1-Associated Neurocognitive Disorders?小胶质细胞:HIV-1相关神经认知障碍中的真正敌人?
Biomedicines. 2021 Jul 30;9(8):925. doi: 10.3390/biomedicines9080925.
10
"I would really want to know that they had my back": Transgender women's perceptions of HIV cure-related research in the United States.“我真的很想知道他们会支持我”:美国跨性别女性对 HIV 治愈相关研究的看法。
PLoS One. 2020 Dec 31;15(12):e0244490. doi: 10.1371/journal.pone.0244490. eCollection 2020.

本文引用的文献

1
Didehydro-Cortistatin A Inhibits HIV-1 by Specifically Binding to the Unstructured Basic Region of Tat.去氢皮质甾酮 A 通过特异性结合 Tat 的无规则碱性区抑制 HIV-1。
mBio. 2019 Feb 5;10(1):e02662-18. doi: 10.1128/mBio.02662-18.
2
Reiterative Enrichment and Authentication of CRISPRi Targets (REACT) identifies the proteasome as a key contributor to HIV-1 latency.CRISPRi 靶点的重复富集和验证(REACT)鉴定蛋白酶体为 HIV-1 潜伏期的关键贡献者。
PLoS Pathog. 2019 Jan 15;15(1):e1007498. doi: 10.1371/journal.ppat.1007498. eCollection 2019 Jan.
3
Hematopoietic Stem and Progenitor Cells Are a Distinct HIV Reservoir that Contributes to Persistent Viremia in Suppressed Patients.造血干细胞和祖细胞是一个独特的 HIV 储库,导致抑制患者持续病毒血症。
Cell Rep. 2018 Dec 26;25(13):3759-3773.e9. doi: 10.1016/j.celrep.2018.11.104.
4
Prevention of SIVmac251 reservoir seeding in rhesus monkeys by early antiretroviral therapy.早期抗逆转录病毒疗法预防恒河猴 SIVmac251 储存库播种。
Nat Commun. 2018 Dec 21;9(1):5429. doi: 10.1038/s41467-018-07881-9.
5
A majority of HIV persistence during antiretroviral therapy is due to infected cell proliferation.在抗逆转录病毒治疗期间,大多数 HIV 持续存在是由于受感染细胞的增殖。
Nat Commun. 2018 Nov 16;9(1):4811. doi: 10.1038/s41467-018-06843-5.
6
HIV control: Is getting there the same as staying there?艾滋病毒控制:到达终点是否等同于保持在终点?
PLoS Pathog. 2018 Nov 1;14(11):e1007222. doi: 10.1371/journal.ppat.1007222. eCollection 2018 Nov.
7
The role of integration and clonal expansion in HIV infection: live long and prosper.整合与克隆性扩张在 HIV 感染中的作用:生生不息。
Retrovirology. 2018 Oct 23;15(1):71. doi: 10.1186/s12977-018-0448-8.
8
Recent progress in broadly neutralizing antibodies to HIV.HIV 广谱中和抗体的最新进展。
Nat Immunol. 2018 Nov;19(11):1179-1188. doi: 10.1038/s41590-018-0235-7. Epub 2018 Oct 17.
9
Mechanisms That Contribute to a Profound Reduction of the HIV-1 Reservoir After Allogeneic Stem Cell Transplant.异体造血干细胞移植后 HIV-1 储存库深度减少的机制。
Ann Intern Med. 2018 Nov 20;169(10):674-683. doi: 10.7326/M18-0759. Epub 2018 Oct 16.
10
Ongoing HIV Replication During ART Reconsidered.抗逆转录病毒治疗期间持续的HIV复制再探讨。
Open Forum Infect Dis. 2017 Sep 19;4(3):ofx173. doi: 10.1093/ofid/ofx173. eCollection 2017 Summer.